Similar Articles

Risk of tuberculosis in children with rheumatologic diseases treated with biological agents: A cross-sectional cohort study

Nuri Bayram, Özge Altuğ Gücenmez, Balahan Makay, Elif Kıymet, Elif Böncüoğlu, Şahika Şahinkaya, Yelda Sorguç, Aybüke Akaslan Kara, Kamile Ötiken Arıkan, İlker Devrim

DOI: 10.46497/ArchRheumatol.2023.9900

Issue: Volume 38 - Issue 4 - December 2023
1041 815

Risk of flare in juvenile idiopathic arthritis: Is it related to the methotrexate treatment strategy or patient characteristics?

Rana İşgüder, Zehra Kızıldağ, Rüya Torun, Tuncay Aydın, Balahan Makay, Erbil Ünsal

DOI: 10.46497/ArchRheumatol.2023.10035

Issue: Volume 38 - Issue 4 - December 2023
1115 864

New and future perspectives in familial Mediterranean fever and other autoinflammatory diseases

Veysel Çam, Hülya Ercan Emreol, Seza Ozen

DOI: 10.46497/ArchRheumatol.2024.10911

Issue: Volume 39 - Issue 3 - September 2024
921 797

Prevalence and characteristics of juvenile fibromyalgia syndrome in pediatric rheumatic diseases: A comparative study

Gülcan Özomay Baykal, Duygu Kurtuluş, Serap Ata, Betül Sözeri

DOI: 10.46497/ArchRheumatol.2024.10562

Issue: Volume 39 - Issue 3 - September 2024
619 458

Relationship between IgA vasculitis and prothrombotic risk factors: A prospective, case-control study

Cengiz Zeybek, Ahmet Bolat, Orhan Gürsel, Bülent Hacıhamdioğlu, Ahmet Emin Kürekçi

DOI: 10.46497/ArchRheumatol.2024.10711

Issue: Volume 39 - Issue 4 - December 2024
33 86